Dividends
MPW

Medical Properties Trust, Inc. (MPW) Ex-Dividend Date Scheduled for September 09, 2020

Medical Properties Trust, Inc. (MPW) will begin trading ex-dividend on September 09, 2020. A cash dividend payment of $0.27 per share is scheduled to be paid on October 08, 2020. Shareholders who purchased MPW prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that MPW has paid the same dividend. At the current stock price of $18.4, the dividend yield is 5.87%.

The previous trading day's last sale of MPW was $18.4, representing a -24.24% decrease from the 52 week high of $24.29 and a 48.99% increase over the 52 week low of $12.35.

MPW is a part of the Consumer Services sector, which includes companies such as American Tower Corporation (REIT) (AMT) and Prologis, Inc. (PLD). MPW's current earnings per share, an indicator of a company's profitability, is $.82. Zacks Investment Research reports MPW's forecasted earnings growth in 2020 as 18.27%, compared to an industry average of -4.5%.

For more information on the declaration, record and payment dates, visit the MPW Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.

Interested in gaining exposure to MPW through an Exchange Traded Fund [ETF]?
The following ETF(s) have MPW as a top-10 holding:

  • WisdomTree U.S. Dividend ex-Financials Fund (DTN)
  • Vanguard S&P Mid-Cap 400 Value ETF (IVOV)
  • iShares S&P Mid-Cap 400 Value ETF (IJJ)
  • SPDR S&P 400 Mid Cap Value ETF (based on S&P MidCap 400 Value (MDYV)
  • First Trust Multi-Asset Diversified Income Index Fund (MDIV).

The top-performing ETF of this group is IVOV with an increase of 25.15% over the last 100 days. DTN has the highest percent weighting of MPW at 1.68%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MPW

NASDAQ.com

Nasdaq

Get the latest stock market news, stock information & quotes, data analysis reports, as well as a general overview of the market landscape from Nasdaq.

Read Nasdaq.com's Bio